NEO
Neogenomics IncCompany with tickers: NEO
CIK
1077183
CUSIP
64049M209
Shares Outstanding
130,211,780
Website
https://www.neogenomics.com
Investor Relations
https://ir.neogenomics.com/
13F Activity (30d)
25 filings
12 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $80,864,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Expenses | $99,105,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Research & Development | $9,534,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Income | $-18,241,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Net Income | $-17,106,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |